Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
15,213 questions in 2,394 reviews
current versionsNo studies 15,213 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Regular‐dose postoperative 5‐Fluorouracil vs control Mean intraocular pressure at 12 months · participants with glaucoma surgery 5‐Fluorouracil for glaucoma surgery (2014) · Cochrane | no estimate extracted | NR | No studies |
Low‐dose postoperative 5‐Fluorouracil vs control Complications ‐ hypotonous maculopathy ‐ not reported · participants with glaucoma surgery 5‐Fluorouracil for glaucoma surgery (2014) · Cochrane | no estimate extracted | NR | No studies |
Low‐dose postoperative 5‐Fluorouracil vs control Complications ‐ shallow anterior chamber ‐ not reported · participants with glaucoma surgery 5‐Fluorouracil for glaucoma surgery (2014) · Cochrane | no estimate extracted | NR | No studies |
Low‐dose postoperative 5‐Fluorouracil vs control Complications ‐ epithelial toxicity ‐ not reported · participants with glaucoma surgery 5‐Fluorouracil for glaucoma surgery (2014) · Cochrane | no estimate extracted | NR | No studies |
Regular‐dose postoperative 5‐Fluorouracil vs control Complications ‐ hypotonous maculopathy · participants with glaucoma surgery 5‐Fluorouracil for glaucoma surgery (2014) · Cochrane | no estimate extracted | NR | No studies |
Bromhexine vs placebo Frequency and duration of exacerbations · patients with bronchiectasis Mucolytics for bronchiectasis (2014) · Cochrane | no estimate extracted | NR | No studies |
RhDNase vs placebo Adverse events · patients with bronchiectasis Mucolytics for bronchiectasis (2014) · Cochrane | no estimate extracted | NR | No studies |
RhDNase vs placebo Health‐related quality of life · patients with bronchiectasis Mucolytics for bronchiectasis (2014) · Cochrane | no estimate extracted | NR | No studies |
Erdosteine vs no treatment Frequency and duration of exacerbations · patients with bronchiectasis Mucolytics for bronchiectasis (2014) · Cochrane | no estimate extracted | NR | No studies |
Erdosteine vs no treatment Hospitalisations for infective exacerbations · patients with bronchiectasis Mucolytics for bronchiectasis (2014) · Cochrane | no estimate extracted | NR | No studies |
Erdosteine vs no treatment Adverse events · patients with bronchiectasis Mucolytics for bronchiectasis (2014) · Cochrane | no estimate extracted | NR | No studies |
Erdosteine vs no treatment Health‐related quality of life · patients with bronchiectasis Mucolytics for bronchiectasis (2014) · Cochrane | no estimate extracted | NR | No studies |
Bromhexine vs placebo Hospitalisations · patients with bronchiectasis Mucolytics for bronchiectasis (2014) · Cochrane | no estimate extracted | NR | No studies |
Erdosteine vs no treatment Deaths · patients with bronchiectasis Mucolytics for bronchiectasis (2014) · Cochrane | no estimate extracted | NR | No studies |
Bromhexine vs placebo Health‐related quality of life · patients with bronchiectasis Mucolytics for bronchiectasis (2014) · Cochrane | no estimate extracted | NR | No studies |
Bromhexine vs placebo Deaths · patients with bronchiectasis Mucolytics for bronchiectasis (2014) · Cochrane | no estimate extracted | NR | No studies |
RhDNase vs placebo Frequency and duration of exacerbations · patients with bronchiectasis Mucolytics for bronchiectasis (2014) · Cochrane | no estimate extracted | NR | No studies |
FLUPENTHIXOL DECANOATE vs ORAL ANTIPSYCHOTICS Clinical response: mental state ‐ relapse ‐ medium term ‐ not reported · patients with schizophrenia or other similar psychotic disorders Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders (2014) · Cochrane | no estimate extracted | NR | No studies |
FLUPENTHIXOL DECANOATE vs OTHER DEPOT ANTIPSYCHOTICS Service utilisation: hospital admission ‐ medium/long term ‐ not reported · patients with schizophrenia or other similar psychotic disorders Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders (2014) · Cochrane | no estimate extracted | NR | No studies |
FLUPENTHIXOL DECANOATE vs OTHER DEPOT ANTIPSYCHOTICS Economic outcomes ‐ long term ‐ not reported · patients with schizophrenia or other similar psychotic disorders Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders (2014) · Cochrane | no estimate extracted | NR | No studies |
FLUPENTHIXOL DECANOATE HIGH DOSE vs FLUPENTHIXOL DECANOATE STANDARD DOSE (˜40 mg/IM) Clinical response: global state ‐ no clinical improvement ‐ short/medium term ‐ not reported · patients with schizophrenia or other similar psychotic disorders Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders (2014) · Cochrane | no estimate extracted | NR | No studies |
FLUPENTHIXOL DECANOATE HIGH DOSE vs FLUPENTHIXOL DECANOATE STANDARD DOSE (˜40 mg/IM) Service utilisation: hospital admission ‐ medium/long term ‐ not reported · patients with schizophrenia or other similar psychotic disorders Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders (2014) · Cochrane | no estimate extracted | NR | No studies |
FLUPENTHIXOL DECANOATE vs ORAL ANTIPSYCHOTICS Clinical response: mental state ‐ general score ‐ medium term ‐ not reported · patients with schizophrenia or other similar psychotic disorders Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders (2014) · Cochrane | no estimate extracted | NR | No studies |
FLUPENTHIXOL DECANOATE HIGH DOSE vs FLUPENTHIXOL DECANOATE STANDARD DOSE (˜40 mg/IM) Economic outcomes ‐ long term ‐ not reported · patients with schizophrenia or other similar psychotic disorders Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders (2014) · Cochrane | no estimate extracted | NR | No studies |
FLUPENTHIXOL DECANOATE VERY LOW (˜6 mg/IM) DOSE vs FLUPENTHIXOL DECANOATE LOW DOSE (˜9 mg/IM) Clinical response: mental state ‐ general score (BPRS) ‐ skew ‐ not reported · patients with schizophrenia or other similar psychotic disorders Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders (2014) · Cochrane | no estimate extracted | NR | No studies |
FLUPENTHIXOL DECANOATE VERY LOW (˜6 mg/IM) DOSE vs FLUPENTHIXOL DECANOATE LOW DOSE (˜9 mg/IM) Clinical response: global state ‐ no clinical improvement ‐ short/medium term ‐ not reported · patients with schizophrenia or other similar psychotic disorders Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders (2014) · Cochrane | no estimate extracted | NR | No studies |
FLUPENTHIXOL DECANOATE VERY LOW (˜6 mg/IM) DOSE vs FLUPENTHIXOL DECANOATE LOW DOSE (˜9 mg/IM) Service utilisation: hospital admission ‐ medium/long term ‐ not reported · patients with schizophrenia or other similar psychotic disorders Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders (2014) · Cochrane | no estimate extracted | NR | No studies |
FLUPENTHIXOL DECANOATE VERY LOW (˜6 mg/IM) DOSE vs FLUPENTHIXOL DECANOATE LOW DOSE (˜9 mg/IM) Leaving the study early ‐ medium/long term ‐ not reported · patients with schizophrenia or other similar psychotic disorders Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders (2014) · Cochrane | no estimate extracted | NR | No studies |
FLUPENTHIXOL DECANOATE VERY LOW (˜6 mg/IM) DOSE vs FLUPENTHIXOL DECANOATE LOW DOSE (˜9 mg/IM) Adverse effects: general ‐ movement disorders ‐ requiring anticholinergic medication ‐ short/medium term ‐ not reported · patients with schizophrenia or other similar psychotic disorders Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders (2014) · Cochrane | no estimate extracted | NR | No studies |
FLUPENTHIXOL DECANOATE VERY LOW (˜6 mg/IM) DOSE vs FLUPENTHIXOL DECANOATE LOW DOSE (˜9 mg/IM) Economic outcomes ‐ long term ‐ not reported · patients with schizophrenia or other similar psychotic disorders Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders (2014) · Cochrane | no estimate extracted | NR | No studies |
FLUPENTHIXOL DECANOATE vs ORAL ANTIPSYCHOTICS Clinical response: global state ‐ no clinical improvement ‐ medium term ‐ not reported · patients with schizophrenia or other similar psychotic disorders Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders (2014) · Cochrane | no estimate extracted | NR | No studies |
FLUPENTHIXOL DECANOATE vs ORAL ANTIPSYCHOTICS Service utilisation: hospital admission ‐ medium/long term ‐ not reported · patients with schizophrenia or other similar psychotic disorders Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders (2014) · Cochrane | no estimate extracted | NR | No studies |
FLUPENTHIXOL DECANOATE vs ORAL ANTIPSYCHOTICS Economic outcomes ‐ long term ‐ not reported · patients with schizophrenia or other similar psychotic disorders Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders (2014) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings: intervention vs usual care or attention control Independence in ADL scales Persisting outcome · adults with stroke Physical rehabilitation approaches for the recovery of function and mobility following stroke (2014) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings: intervention vs usual care or attention control Balance (Berg Balance Scale) Persisting outcome · adults with stroke Physical rehabilitation approaches for the recovery of function and mobility following stroke (2014) · Cochrane | no estimate extracted | NR | No studies |
Volume‐cycled ventilation vs pressure‐cycled ventilation Unplanned admission to hospital ‐ not measured · patients with neuromuscular and chest wall disorders and chronic hypoventilation Nocturnal mechanical ventilation for chronic hypoventilation in patients with neuromuscular and chest wall… (2014) · Cochrane | no estimate extracted | NR | No studies |
Volume‐cycled ventilation vs pressure‐cycled ventilation No improvement of hypoventilation symptoms: long‐term ‐ not measured · patients with neuromuscular and chest wall disorders and chronic hypoventilation Nocturnal mechanical ventilation for chronic hypoventilation in patients with neuromuscular and chest wall… (2014) · Cochrane | no estimate extracted | NR | No studies |
Volume‐cycled ventilation vs pressure‐cycled ventilation No improvement of daytime hypercapnia: long‐term ‐ not measured · patients with neuromuscular and chest wall disorders and chronic hypoventilation Nocturnal mechanical ventilation for chronic hypoventilation in patients with neuromuscular and chest wall… (2014) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Fever after initiation of treatment · elderly people with no influenza A infection (prevention) or with influenza A infection (treatment) Amantadine and rimantadine for influenza A in children and the elderly (2014) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Cough after initiation of treatment · elderly people with no influenza A infection (prevention) or with influenza A infection (treatment) Amantadine and rimantadine for influenza A in children and the elderly (2014) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Dizziness ( · elderly people with no influenza A infection (prevention) or with influenza A infection (treatment) Amantadine and rimantadine for influenza A in children and the elderly (2014) · Cochrane | no estimate extracted | NR | No studies |
Perazine vs other antipsychotics Satisfaction with care ‐ not reported · patients with schizophrenia Perazine for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
Perazine vs other antipsychotics Quality of life ‐ not reported · patients with schizophrenia Perazine for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
Perazine vs placebo Satisfaction with care ‐ not reported · patients with schizophrenia Perazine for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
Perazine vs placebo Quality of life ‐ not reported · patients with schizophrenia Perazine for schizophrenia (2014) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Radiographic joint changes · patients with treating osteoarthritis Oral herbal therapies for treating osteoarthritis (2014) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Quality of life · patients with treating osteoarthritis Oral herbal therapies for treating osteoarthritis (2014) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Radiographic joint changes · patients with treating osteoarthritis Oral herbal therapies for treating osteoarthritis (2014) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Quality of life · patients with treating osteoarthritis Oral herbal therapies for treating osteoarthritis (2014) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Adverse events Participants (n) withdrew due to adverse effects · patients with treating osteoarthritis Oral herbal therapies for treating osteoarthritis (2014) · Cochrane | no estimate extracted | NR | No studies |